RxDoctor Payments DataLook up a doctor →

LEVULAN KERASTICK: payments to doctors

Payments that named LEVULAN KERASTICK as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$1.1M
Providers
2,507
Transactions
5,270
Average per transaction
$202

The per-transaction average — $202 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,507 providers the average total is $424, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
SUN Pharmaceutical Industries Inc.$625,73058.8%
DUSA Pharmaceuticals, Inc.$245,76023.1%
Sun Pharmaceutical Industries Inc.$192,32718.1%
← All drugs & devices